Amanote Research

Amanote Research

    RegisterSign In

Targeting Melanoma Residual Disease by USP7

Oncotarget - United States
doi 10.18632/oncotarget.26497
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

December 15, 2018

Authors
Monika VishnoiDario Marchetti
Publisher

Impact Journals, LLC


Related search

On the Way to Specifically Targeting Minimal Residual Disease?

Breast Cancer Research
Cancer ResearchOncology
2008English

Targeting Melanoma by Small Molecules: Challenges Ahead

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2013English

Targeting Metastatic Melanoma

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

miR-137 Regulates Ferroptosis by Targeting Glutamine Transporter SLC1A5 in Melanoma

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

Targeting Melanoma With Cancer-Killing Viruses

The Open Virology Journal
2017English

Minimal Residual Disease

Leukemia Supplements
2012English

MicroRNA-605 Functions as a Tumor Suppressor by Targeting INPP4B in Melanoma

Oncology Reports
MedicineCancer ResearchOncology
2017English

Minimal Residual Disease

Bone Marrow Transplantation
TransplantationHematology
2001English

Targeting Sphingosine Kinase-1 to Inhibit Melanoma

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy